In our Next in Health podcast, PwC specialists dive into four areas the pharma c-suite should focus on to thrive in 2023. Topics include:  

• Impacts and adjustments resulting from the Inflation Reduction Act
• Strategies companies can use to deal with cost pressures while driving value
• How digital technologies are helping to empower growth and differentiation across the value chain
• Expectations for M&A in 2023

Speakers
Jenny Colapietro, Health Industries Vice Chair, PwC 
Igor Belokrinitsky, Strategy& Principal, PwC 
Glenn Hunzinger, Pharmaceutical and Life Sciences Consulting Leader, PwC 
Greg Rotz, Pharmaceutical and Life Sciences Transformation Leader, PwC 

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.